By yourNEWS Media Newsroom
Regular consumption of anthocyanins, naturally occurring compounds found in blueberries, blackberries, cherries and other deeply colored plant foods, is associated with a 26% lower risk of cardiovascular disease and measurable improvements in blood vessel function, according to a major scientific review examining their effects on otherwise healthy adults.
The research, published in The American Journal of Clinical Nutrition, combined findings from 18 prospective cohort studies and 65 randomized controlled trials to evaluate whether anthocyanins could help prevent cardiovascular and metabolic diseases before they develop.
The study, published online June 18, 2026, involved researchers from Tufts Medical Center, Tufts University, the University of East Anglia and Queen’s University Belfast. It examined evidence specifically involving people without diagnosed cardiometabolic disease, distinguishing it from earlier reviews that included patients with existing medical conditions.
Researchers found that participants consuming the highest amounts of anthocyanins had a 26% lower incidence of cardiovascular disease than those consuming the lowest amounts. Higher intake was also associated with an 18% reduction in heart attack risk, an 11% lower risk of type 2 diabetes, a 9% reduction in cardiovascular mortality and an 8% lower likelihood of developing hypertension.
The analysis included 27 publications reporting findings from 18 prospective cohorts, allowing investigators to examine associations between habitual anthocyanin consumption and health outcomes over time.
Anthocyanins belong to a class of plant compounds called flavonoids, which contribute to the red, purple and blue pigmentation of many fruits and vegetables. They are particularly abundant in blueberries, blackberries, blackcurrants, purple grapes, cherries, red cabbage and other colorful plant foods.
Scientists have investigated these compounds for their potential effects on blood vessel function, inflammation and processes involved in cardiovascular disease.
One of the study’s most significant findings involved endothelial function, which describes the ability of blood vessels to expand and contract in response to changes in blood flow.
Researchers evaluated this function using flow-mediated dilation, a clinical measurement of how effectively an artery widens following a temporary restriction in blood flow.
Across randomized controlled trials, anthocyanin consumption produced measurable improvements in this indicator.
Short-term exposure, defined as one day or less, improved flow-mediated dilation by an average of 1.50 percentage points. Longer-term consumption improved the measurement by an average of 1.41 percentage points.
The researchers rated the evidence supporting short-term improvements as strong and the evidence for longer-term improvements as moderate.
Improved endothelial function is significant because dysfunction of the blood vessel lining is associated with the development of atherosclerosis, a condition involving plaque accumulation in arteries that can contribute to heart attacks and strokes.
The analysis found that beneficial vascular effects occurred with anthocyanin intakes as low as 50 milligrams per day, an amount that can be obtained through ordinary dietary sources depending on the food and its anthocyanin content.
Researchers also examined whether individual anthocyanin compounds produced different physiological effects.
Cyanidin, found in foods such as blackberries and cherries, was associated with improved longer-term flow-mediated dilation. Delphinidin, present in blueberries, blackcurrants and certain other deeply pigmented foods, demonstrated benefits in both short-term and longer-term vascular function.
Delphinidin was also associated with improvements in pulse wave velocity, a measure of arterial stiffness, along with modest reductions in insulin concentrations and triglycerides.
The findings suggest that different anthocyanin compounds may influence cardiovascular and metabolic health through somewhat different biological mechanisms.
However, the randomized trials did not demonstrate significant overall improvements in blood pressure, cholesterol levels, blood glucose or measures of insulin resistance. The researchers also found no significant association between anthocyanin intake and stroke risk in the long-term observational studies.
These distinctions are important because the findings do not establish that anthocyanins prevent every form of cardiovascular disease or consistently improve all metabolic health indicators.
The long-term population studies identified associations between greater anthocyanin consumption and lower disease risk, but observational research cannot establish that the compounds themselves caused those reductions.
People who regularly consume anthocyanin-rich foods may also have other dietary or lifestyle characteristics that contribute to better cardiovascular outcomes.
The clinical trials provided stronger evidence that consuming anthocyanins can improve certain measures of vascular function, although improvements in these measurements do not necessarily establish that supplementation prevents future heart attacks.
A separate study published in the Journal of the American Heart Association in October 2026 illustrates the complexity of the evidence.
That investigation examined anthocyanin and blueberry consumption among women participating in the Women’s Health Study over a median follow-up period of 28 years. Researchers documented 2,752 major cardiovascular events but found no statistically significant association between anthocyanin intake and cardiovascular disease after accounting for clinical, lifestyle and dietary factors.
The investigators did identify associations between higher anthocyanin consumption and more favorable HDL cholesterol and triglyceride measurements.
Taken together, the findings indicate that anthocyanins may contribute to cardiovascular health, particularly through their effects on blood vessel function, while additional research is needed to determine their independent effects on long-term disease prevention.
The authors of the broader review concluded that the available evidence supports including anthocyanin-rich foods in nutritional recommendations intended to reduce cardiovascular risk.
The research was supported in part by the U.S. Highbush Blueberry Council, with oversight from the U.S. Department of Agriculture. The authors reported that the funder did not participate in study selection, quality assessment, statistical analysis or manuscript preparation.
The findings add to scientific evidence supporting the consumption of fruits and vegetables as part of a balanced dietary pattern.
For healthy adults, incorporating blueberries and other anthocyanin-rich foods may provide cardiovascular benefits beyond their conventional nutritional contributions, although researchers caution that the observed associations should not be interpreted as proof that any single food or supplement can prevent heart disease.
Original article


Comments